In postmenopausal women receiving adjuvant AIs for HR-positive EBC, a policy of baseline and annual BMD screening followed by selective treatment with oral bisphosphonates for those diagnosed with osteoporosis is a cost-effective use of societal resources.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Brigham and Women’sHospital, Boston, MA, USA. kito5 [at] partners.org
J Clin Oncol. 2012 May;30(13):1468-75
© Galenicom 1999-2013